Modern Authentication of Pharmaceuticals Act of 2025
This bill requires manufacturers to include a unique physical or chemical identifier on each pill of certain controlled substances in solid oral dosage form (like tablets or capsules). It directly affects pharmaceutical companies producing these specific medications, mandating the identifier to be added to every dose manufactured five years after the bill's enactment. The identifier must be machine-readable and help verify the product's authenticity throughout the supply chain. This change aims to improve tracking and combat counterfeit drugs in the distribution system.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2025
Committee Review
Floor Vote
President
Introduced Feb 6, 2025
Last action Feb 6, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
1
Feb 6, 2025
Committee
Referred to the House Committee on Energy and Commerce.
lower
Feb 6, 2025
Introduced
Introduced in House
lower
1 primary · 3 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Donald G. Davis
DDemocratic
Co
Brian K. Fitzpatrick
RRepublican
Co
Don Bacon
RRepublican
Co
John H. Rutherford
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 1060
Scope: US
Hi! I can help you understand HR 1060. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline